These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
695 related items for PubMed ID: 21858912
1. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma. Samuel D, Colombo M, El-Serag H, Sobesky R, Heaton N. Liver Transpl; 2011 Oct; 17 Suppl 2():S6-13. PubMed ID: 21858912 [Abstract] [Full Text] [Related]
2. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience. Schwartz JJ, Pappas L, Thiesset HF, Vargas G, Sorensen JB, Kim RD, Hutson WR, Boucher K, Box T. Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078 [Abstract] [Full Text] [Related]
3. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria. Kim JM, Kwon CH, Joh JW, Choi MS, Lee JH, Koh KC, Paik SW, Kim GS, Kim SJ, Lee SK, Yoo BC. Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028 [Abstract] [Full Text] [Related]
4. Impact of model for end-stage liver disease score on long-term survival following liver transplantation for hepatocellular carcinoma. Roma J, Balbi E, Pacheco-Moreira L, Zyngier I, Araujo A, Agoglia L, Steinbruck K, Velaverde LG, Martinho JM. Transplant Proc; 2012 Oct; 44(8):2423-7. PubMed ID: 23026611 [Abstract] [Full Text] [Related]
5. The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program. Nemes B, Gelley F, Piros L, Zádori G, Görög D, Fehérvári I, Kóbori L, Sárváry E, Nagy P, Kiss A, Doros A. Transplant Proc; 2011 May; 43(4):1272-4. PubMed ID: 21620108 [Abstract] [Full Text] [Related]
6. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil. Pestana RC, Baracat EI, Massarollo PC, Pereira LA, Szutan LA. Transplant Proc; 2013 May; 45(6):2111-4. PubMed ID: 23747144 [Abstract] [Full Text] [Related]
7. Current controversies surrounding liver transplantation for hepatocellular carcinoma. Silva MF, Wigg AJ. J Gastroenterol Hepatol; 2010 Jul; 25(7):1217-26. PubMed ID: 20594247 [Abstract] [Full Text] [Related]
8. Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria. Felga G, Evangelista AS, Salvalaggio PR, Curvelo LA, Della Guardia B, Almeida MD, Afonso RC, Ferraz-Neto BH. Transplant Proc; 2012 Oct; 44(8):2459-61. PubMed ID: 23026620 [Abstract] [Full Text] [Related]
9. Living donor liver transplantation for hepatocellular carcinoma. Isik B, Ince V, Karabulut K, Kayaalp C, Yilmaz S. Transplant Proc; 2012 Oct; 44(6):1713-6. PubMed ID: 22841251 [Abstract] [Full Text] [Related]
11. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria. Santoyo J, Sanchez B, de la Mata M, Fernández-Aguilar JL, Lopez-Ciller P, Pascasio JM, Suarez MA, Gomez MA, Nogueras F, Muffak K, Cuende N, Alonso M. Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412 [Abstract] [Full Text] [Related]
12. Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy. Cucchetti A, Cescon M, Bigonzi E, Piscaglia F, Golfieri R, Ercolani G, Cristina Morelli M, Ravaioli M, Daniele Pinna A. Liver Transpl; 2011 Nov; 17(11):1344-54. PubMed ID: 21837731 [Abstract] [Full Text] [Related]
13. Liver transplantation for hepatocellular carcinoma: defining the impact of using extended criteria liver allografts. Facciuto ME, Singh MK, Katta U, Samaniego S, Sharma J, Rodriguez-Davalos M, Sheiner P, Kim-Schluger L, Wolf DC. Transplantation; 2011 Aug 27; 92(4):446-52. PubMed ID: 21694662 [Abstract] [Full Text] [Related]
14. Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma. de Ataide EC, Garcia M, Mattosinho TJ, Almeida JR, Escanhoela CA, Boin IF. Transplant Proc; 2012 Oct 27; 44(8):2438-40. PubMed ID: 23026614 [Abstract] [Full Text] [Related]
15. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Herrero JI, Sangro B, Pardo F, Quiroga J, Iñarrairaegui M, Rotellar F, Montiel C, Alegre F, Prieto J. Liver Transpl; 2008 Mar 27; 14(3):272-8. PubMed ID: 18306328 [Abstract] [Full Text] [Related]
16. Adoption of new selection criteria on living donor liver transplantation for hepatocellular carcinoma and their impact on the outcome. Azzam AZ, Tanaka K. Hepatogastroenterology; 2011 Mar 27; 58(112):1873-6. PubMed ID: 22234056 [Abstract] [Full Text] [Related]
17. MELDEQ : An alternative Model for End-Stage Liver Disease score for patients with hepatocellular carcinoma. Marvin MR, Ferguson N, Cannon RM, Jones CM, Brock GN. Liver Transpl; 2015 May 27; 21(5):612-22. PubMed ID: 25694099 [Abstract] [Full Text] [Related]
18. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Lee SG, Hwang S, Moon DB, Ahn CS, Kim KH, Sung KB, Ko GY, Park KM, Ha TY, Song GW. Liver Transpl; 2008 Jul 27; 14(7):935-45. PubMed ID: 18581465 [Abstract] [Full Text] [Related]
19. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, Shimada M, Maehara Y. Transplantation; 2007 Apr 15; 83(7):893-9. PubMed ID: 17460559 [Abstract] [Full Text] [Related]
20. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement? Roayaie K, Feng S. Liver Transpl; 2007 Nov 15; 13(11 Suppl 2):S36-43. PubMed ID: 17969067 [Abstract] [Full Text] [Related] Page: [Next] [New Search]